Comparative Study Between Efficacy of Topical Tofacitinib 2% Ointment and Topical Clobetasol Propionate 0.05% Ointment in Hand Eczema.

Study of Efficacy of Topical Tofacitinib 2% Ointment in Hand Eczema.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064779

Enrollment

Registered

2024-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: TOPICAL 2 % tofacitinib gel: TOPICAL 0.05% CLOBETASOL PROPIONATE GEL Intervention2: Tofacitinib: 2% Ointment, JAK STAT inhibitor, to be applied twice daily, over affected area, for 4 w

Eligibility

Inclusion criteria

Inclusion criteria: 1. Have given written consent before any treatment is commenced. 2. Clinically Diagnosed cases of Hand Eczema. 3. Age group above 18 years of age. 4. Not taken any treatment for hand eczema in the past 1 month

Exclusion criteria

Exclusion criteria: 1. Patients with active infection at local site. 2. Women who are pregnant or nursing. 3. Patient on any treatment that will affect the outcome of the drugs under study.

Design outcomes

Primary

Measure	Time frame
Efficacy of Tofacitinib 2% ointmentTimepoint: 4 WEEKS	—

Secondary

Measure	Time frame
Comparison of topical Tofacitinib 2% ointment with topical Clobetasol Propionate 0.05% ointment. To assess side effects of Tofacitinib ointment.Timepoint: 4 WEEKS	—

Countries

India

Contacts

Public ContactDr drishti bhatt

Jawaharlal Nehru medical college Datta Meghe institute of higher education and research

dradarshlata@yahoo.co.in9765404086

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026